Rulemaking History for OTC Colloidal Silver Drug Products

Final Monographs (21 CFR 310.548):
Drug products containing colloidal silver ingredients or silver salts offered over-the-counter (OTC) for the treatment and/or prevention of disease

Colloidal Silver Drug Products

Proposed RuleDateFR Citation
Proposed Rule10/15/199661FR53685
Final RuleDateFR Citation
Final Rule: Classifies silver salts (internal or external use) as nonmonograph8/17/199964FR44653


Page Last Updated: 02/23/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English